Centromere Protein H Is a Novel Prognostic Marker for Human Nonsmall Cell Lung Cancer Progression and Overall Patient Survival.

The article presents a study which aims to investigate the expression pattern and the significance of centromere protein H (CENP-H) in nonsmall cell lung cancer (NSCLC) patients. Expression level of CENP-H in NSCLC tissues were measured by immunohistochemistry staining. The study found higher expression level of CENP-H in cancer cell lines than in normal cells and noncancerous lung tissues. Researchers conclude that CENP-H may by used as biomarker for lung cancer patients.